BB Biotech Balance Sheet Health
Financial Health criteria checks 5/6
BB Biotech has a total shareholder equity of CHF2.4B and total debt of CHF319.4M, which brings its debt-to-equity ratio to 13.4%. Its total assets and total liabilities are CHF2.7B and CHF322.5M respectively. BB Biotech's EBIT is CHF160.8M making its interest coverage ratio 25.7. It has cash and short-term investments of CHF2.7B.
Key information
13.4%
Debt to equity ratio
CHF 319.40m
Debt
| Interest coverage ratio | 25.7x |
| Cash | CHF 2.71b |
| Equity | CHF 2.39b |
| Total liabilities | CHF 322.49m |
| Total assets | CHF 2.71b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0JYO's short term assets (CHF2.7B) exceed its short term liabilities (CHF322.5M).
Long Term Liabilities: 0JYO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 0JYO has more cash than its total debt.
Reducing Debt: 0JYO's debt to equity ratio has increased from 11.3% to 13.4% over the past 5 years.
Debt Coverage: 0JYO's debt is well covered by operating cash flow (32.7%).
Interest Coverage: 0JYO's interest payments on its debt are well covered by EBIT (25.7x coverage).